350 related articles for article (PubMed ID: 32751440)
1. Extracellular Vesicle Membrane-Associated Proteins: Emerging Roles in Tumor Angiogenesis and Anti-Angiogenesis Therapy Resistance.
Ko SY; Naora H
Int J Mol Sci; 2020 Jul; 21(15):. PubMed ID: 32751440
[TBL] [Abstract][Full Text] [Related]
2. Extracellular vesicle-mediated regulation of tumor angiogenesis- implications for anti-angiogenesis therapy.
Zhang S; Yang J; Shen L
J Cell Mol Med; 2021 Mar; 25(6):2776-2785. PubMed ID: 33586248
[TBL] [Abstract][Full Text] [Related]
3. Targeting tumor micro-environment for design and development of novel anti-angiogenic agents arresting tumor growth.
Gacche RN; Meshram RJ
Prog Biophys Mol Biol; 2013 Nov; 113(2):333-54. PubMed ID: 24139944
[TBL] [Abstract][Full Text] [Related]
4. New insights into the regulatory role of microRNA in tumor angiogenesis and clinical implications.
Wang Y; Wang L; Chen C; Chu X
Mol Cancer; 2018 Feb; 17(1):22. PubMed ID: 29415727
[TBL] [Abstract][Full Text] [Related]
5. Noncoding RNAs of Extracellular Vesicles in Tumor Angiogenesis: From Biological Functions to Clinical Significance.
Hu M; Li J; Liu CG; Goh RMWJ; Yu F; Ma Z; Wang L
Cells; 2022 Mar; 11(6):. PubMed ID: 35326397
[TBL] [Abstract][Full Text] [Related]
6. Redundant angiogenic signaling and tumor drug resistance.
Gacche RN; Assaraf YG
Drug Resist Updat; 2018 Jan; 36():47-76. PubMed ID: 29499837
[TBL] [Abstract][Full Text] [Related]
7. Extracellular vesicles in tumor angiogenesis and resistance to anti-angiogenic therapy.
Ye ZW; Yu ZL; Chen G; Jia J
Cancer Sci; 2023 Jul; 114(7):2739-2749. PubMed ID: 37010195
[TBL] [Abstract][Full Text] [Related]
8. Extracellular vesicle communication pathways as regulatory targets of oncogenic transformation.
Choi D; Lee TH; Spinelli C; Chennakrishnaiah S; D'Asti E; Rak J
Semin Cell Dev Biol; 2017 Jul; 67():11-22. PubMed ID: 28077296
[TBL] [Abstract][Full Text] [Related]
9. Pathophysiology of tumor neovascularization.
Furuya M; Nishiyama M; Kasuya Y; Kimura S; Ishikura H
Vasc Health Risk Manag; 2005; 1(4):277-90. PubMed ID: 17315600
[TBL] [Abstract][Full Text] [Related]
10. Tumor-derived extracellular vesicles in angiogenesis.
Song W; Yan D; Wei T; Liu Q; Zhou X; Liu J
Biomed Pharmacother; 2018 Jun; 102():1203-1208. PubMed ID: 29710539
[TBL] [Abstract][Full Text] [Related]
11. Angiogenic factors as potential drug target: efficacy and limitations of anti-angiogenic therapy.
Gacche RN; Meshram RJ
Biochim Biophys Acta; 2014 Aug; 1846(1):161-79. PubMed ID: 24836679
[TBL] [Abstract][Full Text] [Related]
12. The Roles of Extracellular Vesicles in Malignant Melanoma.
Cheng YC; Chang YA; Chen YJ; Sung HM; Bogeski I; Su HL; Hsu YL; Wang HD
Cells; 2021 Oct; 10(10):. PubMed ID: 34685720
[TBL] [Abstract][Full Text] [Related]
13. Clinical implications of angiogenesis in cancers.
Pang RW; Poon RT
Vasc Health Risk Manag; 2006; 2(2):97-108. PubMed ID: 17319453
[TBL] [Abstract][Full Text] [Related]
14. Mechanisms of Drug Resistance in Cancer: The Role of Extracellular Vesicles.
Samuel P; Fabbri M; Carter DRF
Proteomics; 2017 Dec; 17(23-24):. PubMed ID: 28941129
[TBL] [Abstract][Full Text] [Related]
15. Tumour-Endothelial Cell Communications: Important and Indispensable Mediators of Tumour Angiogenesis.
Lopes-Bastos BM; Jiang WG; Cai J
Anticancer Res; 2016 Mar; 36(3):1119-26. PubMed ID: 26977007
[TBL] [Abstract][Full Text] [Related]
16. Exosomes in Angiogenesis and Anti-angiogenic Therapy in Cancers.
Olejarz W; Kubiak-Tomaszewska G; Chrzanowska A; Lorenc T
Int J Mol Sci; 2020 Aug; 21(16):. PubMed ID: 32823989
[TBL] [Abstract][Full Text] [Related]
17. Tumor vasculature: the Achilles' heel of cancer?
Johannessen TC; Wagner M; Straume O; Bjerkvig R; Eikesdal HP
Expert Opin Ther Targets; 2013 Jan; 17(1):7-20. PubMed ID: 23121690
[TBL] [Abstract][Full Text] [Related]
18. Deciphering the messages carried by extracellular vesicles in hematological malignancies.
Longjohn MN; Hudson JBJ; Smith NC; Rise ML; Moorehead PC; Christian SL
Blood Rev; 2021 Mar; 46():100734. PubMed ID: 32736879
[TBL] [Abstract][Full Text] [Related]
19. Anti-angiogenic therapies in cancer: achievements and open questions.
Ruegg C; Mutter N
Bull Cancer; 2007 Sep; 94(9):753-62. PubMed ID: 17878094
[TBL] [Abstract][Full Text] [Related]
20. Role of the microenvironment in tumor growth and in refractoriness/resistance to anti-angiogenic therapies.
Shojaei F; Ferrara N
Drug Resist Updat; 2008 Dec; 11(6):219-30. PubMed ID: 18948057
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
